在患有心房的患者中,心房线粒体处理受损
Julius Ryan D Pronto1,2, Fleur E Mason1,2, Eva A Rog-Zielinska3
1Institute of Pharmacology and Toxicology (J.R.D.P., F.E.M., F.E.F., D.B., P.B., P.J.S., K.R., S.K., N.V.), University Medical Center Göttingen, Germany.
在心房动 (AF) 中,线粒体处理受损,与细胞失序有关. 增强线粒体吸收可能会预防AF患者的心律失常.
科学领域:
- 心脏病学 心脏病学
- 线粒体生物学 线粒体生物学
- 电子生理学 电子生理学
背景情况:
- 线粒体 (Ca2+) 调节心脏的能量.
- 心房动 (AF) 降低了细胞质Ca2+,但其线粒体效应尚不清楚.
研究的目的:
- 调查线粒体Ca2+处理和AF中的氧化还原状态.
- 探索ezetimibe对AF相关的前节律失常活动的影响.
主要方法:
- 隔离的心房肌细胞受到工作负载变化的影响.
- 测量的Ca2+,NAD,P) H/FAD自光.
- 使用先进的显微镜和ezetimibe治疗.
主要成果:
- 在AF中,线粒体Ca2+积累和NAD(P) H/FAD再生受损.
- 由于微管不稳定造成的,sarcoplasmic网膜和线粒体的空间混乱.
- 埃泽蒂米布减少了肌细胞中的心律失常事件和患者的AF负担.
结论:
- 线粒体Ca2+吸收在AF肌细胞中受损.
- 微管不稳定会破坏心脏Ca2+转移.
- 增强线粒体Ca2+吸收可能会提供对AF的保护.
更多相关视频
08:10Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
06:22Isolation of High Quality Murine Atrial and Ventricular Myocytes for Simultaneous Measurements of Ca2+ Transients and L-Type Calcium Current
Published on: November 3, 2020
相关概念视频
Mitral Stenosis I: Introduction
Mechanism of Cardiac Arrhythmias
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Mitral Stenosis II: Clinical features and Diagnostic Tests
